Evidence map›Paper›PMID 32719040›Full record

ArticleAnnals of the rheumatic diseases2021

COVID-19 and Behçet's disease: clinical case series.

Gerard Espinosa, Olga Araujo, Sergi Amaro, Marta Bodro, Pedro Juan Moreno, Reinaldo Moreno, Ainoa Ugarte, R Cervera

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Annals of the rheumatic diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pentoxifylline in COVID-19 and considerations for its research in long COVID.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Ocular Behçet disease and COVID-19.European journal of ophthalmology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Adamantiades-Behçet's disease (Behçet's disease) and COVID-19.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Gerard EspinosaAutoimmune Diseases, University of Barcelona, Barcelona, Catalunya, Spain gespino@clinic.cat.ORCID 0000-0003-1336-0163
Olga AraujoAutoimmune Diseases, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
Sergi AmaroNeurology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
Marta BodroInfectious Diseases, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
Pedro Juan MorenoInternal Medicine, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
Reinaldo MorenoMedical Oncology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
Ainoa UgarteInternal Medicine, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
R CerveraAutoimmune Diseases, Hospital Clinic, Barcelona, Catalunya, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Behcet SyndromeCOVID-19HumansBehcet syndromeepidemiologysystemic vasculitis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.